BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Aslam S, Goldstein DR, Vos R, Gelman AE, Kittleson MM, Wolfe C, Danziger-Isakov L. COVID-19 vaccination in our transplant recipients: The time is now. J Heart Lung Transplant 2021;40:169-71. [PMID: 33487534 DOI: 10.1016/j.healun.2020.12.009] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 13.0] [Reference Citation Analysis]
Number Citing Articles
1 Bery AI, Kulkarni HS, Kreisel D. Editorial: COVID-19 immunology and organ transplantation. Curr Opin Organ Transplant 2021;26:258-65. [PMID: 33651004 DOI: 10.1097/MOT.0000000000000862] [Reference Citation Analysis]
2 Tang WR, Hsu CW, Lee CC, Huang WL, Lin CY, Hsu YT, Chang C, Tsai MT, Hu YN, Hsu CH, Chen PL, Chow NH, Roan JN. A Case Report of Posttransplant Lymphoproliferative Disorder After AstraZeneca Coronavirus Disease 2019 Vaccine in a Heart Transplant Recipient. Transplant Proc 2021:S0041-1345(21)00682-5. [PMID: 34702598 DOI: 10.1016/j.transproceed.2021.09.006] [Reference Citation Analysis]
3 Itzhaki Ben Zadok O, Shaul AA, Ben-Avraham B, Yaari V, Ben Zvi H, Shostak Y, Pertzov B, Eliakim-Raz N, Abed G, Abuhazira M, Barac YD, Mats I, Kramer MR, Aravot D, Kornowski R, Ben-Gal T. Immunogenicity of the BNT162b2 mRNA vaccine in heart transplant recipients - a prospective cohort study. Eur J Heart Fail 2021. [PMID: 33963635 DOI: 10.1002/ejhf.2199] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
4 Scharringa S, Hoffman T, van Kessel DA, Rijkers GT. Vaccination and their importance for lung transplant recipients in a COVID-19 world. Expert Rev Clin Pharmacol 2021;:1-13. [PMID: 34328054 DOI: 10.1080/17512433.2021.1961577] [Reference Citation Analysis]
5 L'Huillier AG, Ardura MI, Chaudhuri A, Danziger-Isakov L, Dulek D, Green M, Michaels MG, Posfay-Barbe KM, Vàsquez L, Benden C. COVID-19 vaccination in pediatric solid organ transplant recipients-Current state and future directions. Pediatr Transplant 2021;25:e14031. [PMID: 34076928 DOI: 10.1111/petr.14031] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Andreoni M, Sticchi L, Nozza S, Sarmati L, Gori A, Tavio M; Society for Infectious and Tropical Diseases (SIMIT). Recommendations of the Italian society for infectious and tropical diseases (SIMIT) for adult vaccinations. Hum Vaccin Immunother 2021;:1-18. [PMID: 34524945 DOI: 10.1080/21645515.2021.1971473] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Notarte KI, Ver AT, Velasco JV, Pastrana A, Catahay JA, Salvagno GL, Yap EPH, Martinez-Sobrido L, B Torrelles J, Lippi G, Henry BM. Effects of age, sex, serostatus, and underlying comorbidities on humoral response post-SARS-CoV-2 Pfizer-BioNTech mRNA vaccination: a systematic review. Crit Rev Clin Lab Sci 2022;:1-18. [PMID: 35220860 DOI: 10.1080/10408363.2022.2038539] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
8 Hoffman TW, Meek B, Rijkers GT, van Kessel DA. Poor Serologic Response to 2 Doses of an mRNA-based SARS-CoV-2 Vaccine in Lung Transplant Recipients. Transplantation 2022;106:e103-4. [PMID: 34699459 DOI: 10.1097/TP.0000000000003966] [Reference Citation Analysis]
9 Mohseni Afshar Z, Babazadeh A, Janbakhsh A, Mansouri F, Sio TT, Sullman MJM, Carson-Chahhoud K, Hosseinzadeh R, Barary M, Ebrahimpour S. Coronavirus disease 2019 (Covid-19) vaccination recommendations in special populations and patients with existing comorbidities. Rev Med Virol 2021;:e2309. [PMID: 34677889 DOI: 10.1002/rmv.2309] [Reference Citation Analysis]
10 Itzhaki Ben Zadok O, Shaul AA, Ben-Avraham B, Yaari V, Ben Zvi H, Eliakim-Raz N, Yahav D, Abed G, Abuhazira M, Barac YD, Mats I, Shochat T, Aravot D, Kornowski R, Ben-Gal T. Six-months immunogenicity of BNT162b2 mRNA vaccine in heart transplanted and ventricle assist device-supported patients. ESC Heart Fail 2022. [PMID: 34981657 DOI: 10.1002/ehf2.13798] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Heldman MR, Limaye AP. SARS-CoV-2 Vaccines in Kidney Transplant Recipients: Will They Be Safe and Effective and How Will We Know? J Am Soc Nephrol 2021;32:1021-4. [PMID: 33762353 DOI: 10.1681/ASN.2021010023] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
12 Loconsole D, Stea ED, Sallustio A, Fontò G, Pronzo V, Simone S, Centrone F, Accogli M, Gesualdo L, Chironna M. Severe COVID-19 by SARS-CoV-2 Lineage B.1.1.7 in Vaccinated Solid-Organ Transplant Recipients: New Preventive Strategies Needed to Protect Immunocompromised Patients. Vaccines (Basel) 2021;9:806. [PMID: 34451931 DOI: 10.3390/vaccines9080806] [Reference Citation Analysis]
13 Moss P, Berenbaum F, Curigliano G, Grupper A, Berg T, Pather S. Benefit–Risk Evaluation of COVID-19 Vaccination in Special Population Groups of Interest. Vaccine 2022. [DOI: 10.1016/j.vaccine.2022.05.067] [Reference Citation Analysis]
14 Kumar N, Rana R, Rana DS, Gupta A, Sachdeva MP. SARS-CoV-2 in Kidney Transplant Recipients: A Systematic Review. Transplantology 2022;3:33-48. [DOI: 10.3390/transplantology3010004] [Reference Citation Analysis]
15 Gut G, Góral A, Dal Canton Z, Poznański P, Krajewska M, Kusztal M. Kidney Transplantation in COVID Pandemic-A Review of Guidelines. J Clin Med 2021;10:2877. [PMID: 34209504 DOI: 10.3390/jcm10132877] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Vnučák M, Graňák K, Beliančinová M, Jeseňák M, Macháleková KK, Benko J, Samoš M, Dedinská I. Acute kidney rejection after anti-SARS-CoV-2 virus-vectored vaccine-case report. NPJ Vaccines 2022;7:30. [PMID: 35236844 DOI: 10.1038/s41541-022-00445-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
17 Yi SG, Moore LW, Eagar T, Graviss EA, Nguyen DT, Ibrahim H, Huang HJ, Hobeika M, McMillan R, Saharia A, Mobley C, Podder H, Drews A, Ghobrial RM, Gaber AO, Knight RJ. Risk Factors Associated With an Impaired Antibody Response in Kidney Transplant Recipients Following 2 Doses of the SARS-CoV-2 mRNA Vaccine. Transplant Direct 2022;8:e1257. [PMID: 34912946 DOI: 10.1097/TXD.0000000000001257] [Reference Citation Analysis]
18 Svorcova M, Novysedlak R, Lischke R, Vachtenheim J Jr, Strizova Z. Vaccination Against SARS-CoV-2 in Lung Transplant Recipients: Immunogenicity, Efficacy and Safety. Front Immunol 2022;13:906225. [PMID: 35720376 DOI: 10.3389/fimmu.2022.906225] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Villar-álvarez F, Martínez-garcía MÁ, Jiménez D, Fariñas-guerrero F, Ortiz de Lejarazu-leonardo R, López-campos JL, Blanco-aparicio M, Royo-crespo Í, García-ortega A, Trilla-garcía A, Trujillo-reyes JC, Fernández-prada M, Díaz-pérez D, Laporta-hernández R, Valenzuela C, Menéndez R, de la Rosa-carrillo D. Recomendaciones SEPAR sobre la vacuna COVID-19 en las enfermedades respiratorias. Open Respiratory Archives 2021;3:100097. [DOI: 10.1016/j.opresp.2021.100097] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
20 Chen T, Li X, Li Q, Huang L, Cai Q, Wang Y, Jiang Y, Xu Q, Lv Q, Wang J. COVID-19 vaccination hesitancy and associated factors among solid organ transplant recipients in China. Hum Vaccin Immunother 2021;:1-8. [PMID: 34586945 DOI: 10.1080/21645515.2021.1984133] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Bhatt AS, Adler ED, Albert NM, Anyanwu A, Bhadelia N, Cooper LT, Correa A, Defilippis EM, Joyce E, Sauer AJ, Solomon SD, Vardeny O, Yancy C, Lala A. Coronavirus Disease-2019 and Heart Failure: A Scientific Statement From the Heart Failure Society of America. J Card Fail 2021:S1071-9164(21)00354-7. [PMID: 34481067 DOI: 10.1016/j.cardfail.2021.08.013] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
22 Nevermann N, Wiering L, Wu H, Moroder P, Brandl A, Globke B, Krenzien F, Raschzok N, Schöning W, Lurje G, Öllinger R, Schmelzle M, Pratschke J, Ritschl PV. Transplantation programs facing lack of empirical evidence on SARS-CoV-2 vaccination: A society recommendation consensus update. Transpl Infect Dis 2021;:e13696. [PMID: 34288294 DOI: 10.1111/tid.13696] [Reference Citation Analysis]
23 Negahdaripour M, Shafiekhani M, Moezzi SMI, Amiri S, Rasekh S, Bagheri A, Mosaddeghi P, Vazin A. Administration of COVID-19 vaccines in immunocompromised patients. Int Immunopharmacol 2021;99:108021. [PMID: 34352567 DOI: 10.1016/j.intimp.2021.108021] [Reference Citation Analysis]